论文部分内容阅读
目的观察小剂量尿激酶治疗脑梗塞41例的疗效。方法选取我院脑梗塞患者41例,随机将患者分为治疗组(20例)和对照组(21例),对照组患者给予抗凝、抗血小板聚集的常规治疗,治疗组在常规治疗基础上加用小剂量尿激酶静脉注射,观察两组患者治疗效果。结果治疗组的总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论小剂量尿激酶静脉注射,对脑梗塞的疗效显著,可改善患者生存质量,值得推广。
Objective To observe the efficacy of low-dose urokinase in treating 41 cases of cerebral infarction. Methods A total of 41 patients with cerebral infarction in our hospital were randomly divided into treatment group (n = 20) and control group (n = 21). Patients in the control group were given routine anticoagulation and antiplatelet therapy. On the basis of routine treatment Plus a small dose of intravenous injection of urokinase to observe the treatment effect of two groups of patients. Results The total effective rate of the treatment group was significantly higher than that of the control group, the difference was statistically significant (P <0.05). Conclusion Intravenous injection of low-dose urokinase has significant therapeutic effect on cerebral infarction, which can improve the quality of life of patients and is worth promoting.